aluates Reports

$ 0.0

Automative

Cephalosporin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-16X255

Global Cephalosporin Market Insights Forecast to 2025

BUY CHAPTERS

Cephalosporin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-16X255

Report

August 2025

Pages:143

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

NCPC

Qilu Antibiotics

Dongying Pharmaceutical

SALUBRIS

LIVZON

CSPC

Orchid Pharma

United Laboratories

Aurobindo

LKPC

HPGC

Nectar Lifesciences

ACS Dobfar

Novartis

Ruiying

Meiya

KELUN

Dongrui

Liguo Pharma

Fuan Pharma

Cephalosporin- Market Size

The global market for Cephalosporin was estimated to be worth US$ 1367 million in 2024 and is forecast to a readjusted size of US$ 1337 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.

Cephalosporin- Market

Cephalosporins are a class of broad-spectrum antibiotics that belong to the β-lactam family, known for their ability to inhibit bacterial cell wall synthesis. They were originally derived from a fungus called Cephalosporium in the 1940s. Cephalosporins are divided into five generations, with each successive generation offering a different spectrum of activity against Gram-positive and Gram-negative bacteria and improved resistance to bacterial enzymes. Due to their effectiveness and relatively low toxicity, cephalosporins are commonly used to treat a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. In this report, we study the Cephalosporin API.

The cephalosporin Market Drivers:

Rising Prevalence of Infectious Diseases: The global increase in bacterial infections, including pneumonia, urinary tract infections, and skin infections, drives demand for cephalosporins. Their broad-spectrum activity makes them a go-to option for treating these infections.

Increasing Antibiotic Resistance: With the rise of antibiotic-resistant strains of bacteria, there is a growing need for newer generations of cephalosporins that are more effective against resistant pathogens. This drives the development and adoption of advanced cephalosporin formulations.

Expanding Healthcare Access in Emerging Markets: Growth in healthcare infrastructure and increased access to antibiotics in developing countries boosts the demand for cephalosporins. These regions are seeing a higher prevalence of infectious diseases, contributing to market growth.

Favorable Government Policies and Initiatives: Many governments and health organizations are investing in programs aimed at reducing infectious diseases, leading to greater usage of antibiotics like cephalosporins. Public health initiatives to combat antimicrobial resistance also support the market.

Advances in Drug Delivery Systems: Innovations in drug formulations and delivery methods, such as extended-release injections or oral formulations, enhance patient compliance and efficacy, driving the market for cephalosporins.

The cephalosporin Challenges:

Growing Antibiotic Resistance: While resistance fuels demand for newer drugs, it also presents a significant challenge. The increasing inefficacy of older-generation cephalosporins against resistant bacteria necessitates ongoing research and development, which can be costly and time-consuming.

Regulatory Hurdles: Stringent regulatory processes for the approval of new antibiotics can delay the launch of advanced cephalosporin drugs. Regulatory agencies are placing stricter requirements on antibiotic approval to ensure safety and efficacy.

Competition from Other Antibiotics: Cephalosporins face competition from other classes of antibiotics, including carbapenems and quinolones, which may be more effective against certain resistant strains. This limits their market share in some regions and applications.

High Cost of R&D: The research and development of new cephalosporins, especially those targeting resistant bacteria, are expensive. Pharmaceutical companies may face challenges in balancing development costs with profitable pricing, especially in low-income markets.

Adverse Effects and Allergic Reactions: Cephalosporins, like all antibiotics, carry a risk of side effects, including allergic reactions and gastrointestinal issues. These risks may limit their use in some patient populations and prompt healthcare providers to seek alternative treatments.

Market competition is intense. Qilu Antibiotics, Nectar Lifesciences, Shandong Ruiying Pioneer Pharmaceutical, NCPC and ACS Dobfar are the top 5 of Cephalosporin, with about 50% market shares.China is the largest supplier of Cephalosporin, with a production market share nearly 70%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 21%.China is the largest consumption place, with a consumption market share nearly 40%. Following China, India is the second largest consumption place with the consumption market share of 39%. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 61%.Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 80%.

This report aims to provide a comprehensive presentation of the global market for Cephalosporin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cephalosporin by region & country, by Type, and by Application.

The Cephalosporin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cephalosporin.

Market Segmentation

Scope of Cephalosporin- Market Report

Report Metric	Details
Report Name	Cephalosporin- Market
Forecasted market size in 2031	US$ 1337 million
Forecasted years	2025 - 2031
Segment by Type	First Generation Cephalosporin Second Generation Cephalosporin Third Generation Cephalosporin Fourth Generation Cephalosporin
Segment by Application	Oral Injection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	NCPC, Qilu Antibiotics, Dongying Pharmaceutical, SALUBRIS, LIVZON, CSPC, United Laboratories, LKPC, HPGC, Ruiying, Meiya, Kelun, Dongrui, Liguo Pharma, Fuan Pharma, Orchid Pharma, Aurobindo, Nectar Lifesciences, ACS Dobfar, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cephalosporin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cephalosporin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cephalosporin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Cephalosporin- Market size in 2031?

Ans: The Cephalosporin- Market size in 2031 will be US$ 1337 million.

What is the market share of major companies in Cephalosporin- Market?

Ans: Qilu Antibiotics, Nectar Lifesciences, Shandong Ruiying Pioneer Pharmaceutical, NCPC and ACS Dobfar are the top 5 of Cephalosporin, with about 50% market shares.

What is the Cephalosporin- Market production share by region?

Ans: China is the largest supplier of Cephalosporin, with a production market share nearly 70%.

What is the Cephalosporin- Market share by application?

Ans: The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 80%.

Who are the main players in the Cephalosporin- Market report?

Ans: The main players in the Cephalosporin- Market are NCPC, Qilu Antibiotics, Dongying Pharmaceutical, SALUBRIS, LIVZON, CSPC, United Laboratories, LKPC, HPGC, Ruiying, Meiya, Kelun, Dongrui, Liguo Pharma, Fuan Pharma, Orchid Pharma, Aurobindo, Nectar Lifesciences, ACS Dobfar, Novartis

What are the Application segmentation covered in the Cephalosporin- Market report?

Ans: The Applications covered in the Cephalosporin- Market report are Oral, Injection

What are the Type segmentation covered in the Cephalosporin- Market report?

Ans: The Types covered in the Cephalosporin- Market report are First Generation Cephalosporin, Second Generation Cephalosporin, Third Generation Cephalosporin, Fourth Generation Cephalosporin

1 Market Overview

1.1 Cephalosporin Product Introduction

1.2 Global Cephalosporin Market Size Forecast

1.2.1 Global Cephalosporin Sales Value (2020-2031)

1.2.2 Global Cephalosporin Sales Volume (2020-2031)

1.2.3 Global Cephalosporin Sales Price (2020-2031)

1.3 Cephalosporin Market Trends & Drivers

1.3.1 Cephalosporin Industry Trends

1.3.2 Cephalosporin Market Drivers & Opportunity

1.3.3 Cephalosporin Market Challenges

1.3.4 Cephalosporin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Cephalosporin Players Revenue Ranking (2024)

2.2 Global Cephalosporin Revenue by Company (2020-2025)

2.3 Global Cephalosporin Players Sales Volume Ranking (2024)

2.4 Global Cephalosporin Sales Volume by Company Players (2020-2025)

2.5 Global Cephalosporin Average Price by Company (2020-2025)

2.6 Key Manufacturers Cephalosporin Manufacturing Base and Headquarters

2.7 Key Manufacturers Cephalosporin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Cephalosporin

2.9 Cephalosporin Market Competitive Analysis

2.9.1 Cephalosporin Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Cephalosporin Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cephalosporin as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 First Generation Cephalosporin

3.1.2 Second Generation Cephalosporin

3.1.3 Third Generation Cephalosporin

3.1.4 Fourth Generation Cephalosporin

3.2 Global Cephalosporin Sales Value by Type

3.2.1 Global Cephalosporin Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Cephalosporin Sales Value, by Type (2020-2031)

3.2.3 Global Cephalosporin Sales Value, by Type (%) (2020-2031)

3.3 Global Cephalosporin Sales Volume by Type

3.3.1 Global Cephalosporin Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Cephalosporin Sales Volume, by Type (2020-2031)

3.3.3 Global Cephalosporin Sales Volume, by Type (%) (2020-2031)

3.4 Global Cephalosporin Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oral

4.1.2 Injection

4.2 Global Cephalosporin Sales Value by Application

4.2.1 Global Cephalosporin Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Cephalosporin Sales Value, by Application (2020-2031)

4.2.3 Global Cephalosporin Sales Value, by Application (%) (2020-2031)

4.3 Global Cephalosporin Sales Volume by Application

4.3.1 Global Cephalosporin Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Cephalosporin Sales Volume, by Application (2020-2031)

4.3.3 Global Cephalosporin Sales Volume, by Application (%) (2020-2031)

4.4 Global Cephalosporin Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Cephalosporin Sales Value by Region

5.1.1 Global Cephalosporin Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Cephalosporin Sales Value by Region (2020-2025)

5.1.3 Global Cephalosporin Sales Value by Region (2026-2031)

5.1.4 Global Cephalosporin Sales Value by Region (%), (2020-2031)

5.2 Global Cephalosporin Sales Volume by Region

5.2.1 Global Cephalosporin Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Cephalosporin Sales Volume by Region (2020-2025)

5.2.3 Global Cephalosporin Sales Volume by Region (2026-2031)

5.2.4 Global Cephalosporin Sales Volume by Region (%), (2020-2031)

5.3 Global Cephalosporin Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Cephalosporin Sales Value, 2020-2031

5.4.2 North America Cephalosporin Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Cephalosporin Sales Value, 2020-2031

5.5.2 Europe Cephalosporin Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Cephalosporin Sales Value, 2020-2031

5.6.2 Asia Pacific Cephalosporin Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Cephalosporin Sales Value, 2020-2031

5.7.2 South America Cephalosporin Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Cephalosporin Sales Value, 2020-2031

5.8.2 Middle East & Africa Cephalosporin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Cephalosporin Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Cephalosporin Sales Value

6.2.1 Key Countries/Regions Cephalosporin Sales Value, 2020-2031

6.2.2 Key Countries/Regions Cephalosporin Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Cephalosporin Sales Value, 2020-2031

6.3.2 United States Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Cephalosporin Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Cephalosporin Sales Value, 2020-2031

6.4.2 Europe Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Cephalosporin Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Cephalosporin Sales Value, 2020-2031

6.5.2 China Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.5.3 China Cephalosporin Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Cephalosporin Sales Value, 2020-2031

6.6.2 Japan Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Cephalosporin Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Cephalosporin Sales Value, 2020-2031

6.7.2 South Korea Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Cephalosporin Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Cephalosporin Sales Value, 2020-2031

6.8.2 Southeast Asia Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Cephalosporin Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Cephalosporin Sales Value, 2020-2031

6.9.2 India Cephalosporin Sales Value by Type (%), 2024 VS 2031

6.9.3 India Cephalosporin Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 NCPC

7.1.1 NCPC Company Information

7.1.2 NCPC Introduction and Business Overview

7.1.3 NCPC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 NCPC Cephalosporin Product Offerings

7.1.5 NCPC Recent Development

7.2 Qilu Antibiotics

7.2.1 Qilu Antibiotics Company Information

7.2.2 Qilu Antibiotics Introduction and Business Overview

7.2.3 Qilu Antibiotics Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Qilu Antibiotics Cephalosporin Product Offerings

7.2.5 Qilu Antibiotics Recent Development

7.3 Dongying Pharmaceutical

7.3.1 Dongying Pharmaceutical Company Information

7.3.2 Dongying Pharmaceutical Introduction and Business Overview

7.3.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Dongying Pharmaceutical Cephalosporin Product Offerings

7.3.5 Dongying Pharmaceutical Recent Development

7.4 SALUBRIS

7.4.1 SALUBRIS Company Information

7.4.2 SALUBRIS Introduction and Business Overview

7.4.3 SALUBRIS Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 SALUBRIS Cephalosporin Product Offerings

7.4.5 SALUBRIS Recent Development

7.5 LIVZON

7.5.1 LIVZON Company Information

7.5.2 LIVZON Introduction and Business Overview

7.5.3 LIVZON Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 LIVZON Cephalosporin Product Offerings

7.5.5 LIVZON Recent Development

7.6 CSPC

7.6.1 CSPC Company Information

7.6.2 CSPC Introduction and Business Overview

7.6.3 CSPC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 CSPC Cephalosporin Product Offerings

7.6.5 CSPC Recent Development

7.7 United Laboratories

7.7.1 United Laboratories Company Information

7.7.2 United Laboratories Introduction and Business Overview

7.7.3 United Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 United Laboratories Cephalosporin Product Offerings

7.7.5 United Laboratories Recent Development

7.8 LKPC

7.8.1 LKPC Company Information

7.8.2 LKPC Introduction and Business Overview

7.8.3 LKPC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 LKPC Cephalosporin Product Offerings

7.8.5 LKPC Recent Development

7.9 HPGC

7.9.1 HPGC Company Information

7.9.2 HPGC Introduction and Business Overview

7.9.3 HPGC Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 HPGC Cephalosporin Product Offerings

7.9.5 HPGC Recent Development

7.10 Ruiying

7.10.1 Ruiying Company Information

7.10.2 Ruiying Introduction and Business Overview

7.10.3 Ruiying Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Ruiying Cephalosporin Product Offerings

7.10.5 Ruiying Recent Development

7.11 Meiya

7.11.1 Meiya Company Information

7.11.2 Meiya Introduction and Business Overview

7.11.3 Meiya Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Meiya Cephalosporin Product Offerings

7.11.5 Meiya Recent Development

7.12 Kelun

7.12.1 Kelun Company Information

7.12.2 Kelun Introduction and Business Overview

7.12.3 Kelun Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Kelun Cephalosporin Product Offerings

7.12.5 Kelun Recent Development

7.13 Dongrui

7.13.1 Dongrui Company Information

7.13.2 Dongrui Introduction and Business Overview

7.13.3 Dongrui Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Dongrui Cephalosporin Product Offerings

7.13.5 Dongrui Recent Development

7.14 Liguo Pharma

7.14.1 Liguo Pharma Company Information

7.14.2 Liguo Pharma Introduction and Business Overview

7.14.3 Liguo Pharma Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Liguo Pharma Cephalosporin Product Offerings

7.14.5 Liguo Pharma Recent Development

7.15 Fuan Pharma

7.15.1 Fuan Pharma Company Information

7.15.2 Fuan Pharma Introduction and Business Overview

7.15.3 Fuan Pharma Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Fuan Pharma Cephalosporin Product Offerings

7.15.5 Fuan Pharma Recent Development

7.16 Orchid Pharma

7.16.1 Orchid Pharma Company Information

7.16.2 Orchid Pharma Introduction and Business Overview

7.16.3 Orchid Pharma Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Orchid Pharma Cephalosporin Product Offerings

7.16.5 Orchid Pharma Recent Development

7.17 Aurobindo

7.17.1 Aurobindo Company Information

7.17.2 Aurobindo Introduction and Business Overview

7.17.3 Aurobindo Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Aurobindo Cephalosporin Product Offerings

7.17.5 Aurobindo Recent Development

7.18 Nectar Lifesciences

7.18.1 Nectar Lifesciences Company Information

7.18.2 Nectar Lifesciences Introduction and Business Overview

7.18.3 Nectar Lifesciences Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.18.4 Nectar Lifesciences Cephalosporin Product Offerings

7.18.5 Nectar Lifesciences Recent Development

7.19 ACS Dobfar

7.19.1 ACS Dobfar Company Information

7.19.2 ACS Dobfar Introduction and Business Overview

7.19.3 ACS Dobfar Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.19.4 ACS Dobfar Cephalosporin Product Offerings

7.19.5 ACS Dobfar Recent Development

7.20 Novartis

7.20.1 Novartis Company Information

7.20.2 Novartis Introduction and Business Overview

7.20.3 Novartis Cephalosporin Sales, Revenue, Price and Gross Margin (2020-2025)

7.20.4 Novartis Cephalosporin Product Offerings

7.20.5 Novartis Recent Development

8 Industry Chain Analysis

8.1 Cephalosporin Industrial Chain

8.2 Cephalosporin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Cephalosporin Sales Model

8.5.2 Sales Channel

8.5.3 Cephalosporin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

NCPC

Qilu Antibiotics

Dongying Pharmaceutical

SALUBRIS

LIVZON

CSPC

Orchid Pharma

United Laboratories

Aurobindo

LKPC

HPGC

Nectar Lifesciences

ACS Dobfar

Novartis

Ruiying

Meiya

KELUN

Dongrui

Liguo Pharma

Fuan Pharma

List of Tables

Table 1. Cephalosporin Market Trends

Table 2. Cephalosporin Market Drivers & Opportunity

Table 3. Cephalosporin Market Challenges

Table 4. Cephalosporin Market Restraints

Table 5. Global Cephalosporin Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Cephalosporin Revenue Market Share by Company (2020-2025)

Table 7. Global Cephalosporin Sales Volume by Company (2020-2025) & (MT)

Table 8. Global Cephalosporin Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Cephalosporin Price by Company (2020-2025) & (USD/Kg)

Table 10. Key Manufacturers Cephalosporin Manufacturing Base and Headquarters

Table 11. Key Manufacturers Cephalosporin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Cephalosporin

Table 13. Global Cephalosporin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cephalosporin as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Cephalosporin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Cephalosporin Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Cephalosporin Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Cephalosporin Sales Market Share in Value by Type (2020-2025)

Table 20. Global Cephalosporin Sales Market Share in Value by Type (2026-2031)

Table 21. Global Cephalosporin Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)

Table 22. Global Cephalosporin Sales Volume by Type (2020-2025) & (MT)

Table 23. Global Cephalosporin Sales Volume by Type (2026-2031) & (MT)

Table 24. Global Cephalosporin Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Cephalosporin Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Cephalosporin Price by Type (2020-2025) & (USD/Kg)

Table 27. Global Cephalosporin Price by Type (2026-2031) & (USD/Kg)

Table 28. Global Cephalosporin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Cephalosporin Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Cephalosporin Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Cephalosporin Sales Market Share in Value by Application (2020-2025)

Table 32. Global Cephalosporin Sales Market Share in Value by Application (2026-2031)

Table 33. Global Cephalosporin Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)

Table 34. Global Cephalosporin Sales Volume by Application (2020-2025) & (MT)

Table 35. Global Cephalosporin Sales Volume by Application (2026-2031) & (MT)

Table 36. Global Cephalosporin Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Cephalosporin Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Cephalosporin Price by Application (2020-2025) & (USD/Kg)

Table 39. Global Cephalosporin Price by Application (2026-2031) & (USD/Kg)

Table 40. Global Cephalosporin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Cephalosporin Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Cephalosporin Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Cephalosporin Sales Value by Region (2020-2025) & (%)

Table 44. Global Cephalosporin Sales Value by Region (2026-2031) & (%)

Table 45. Global Cephalosporin Sales Volume by Region (MT): 2020 VS 2024 VS 2031

Table 46. Global Cephalosporin Sales Volume by Region (2020-2025) & (MT)

Table 47. Global Cephalosporin Sales Volume by Region (2026-2031) & (MT)

Table 48. Global Cephalosporin Sales Volume by Region (2020-2025) & (%)

Table 49. Global Cephalosporin Sales Volume by Region (2026-2031) & (%)

Table 50. Global Cephalosporin Average Price by Region (2020-2025) & (USD/Kg)

Table 51. Global Cephalosporin Average Price by Region (2026-2031) & (USD/Kg)

Table 52. Key Countries/Regions Cephalosporin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Cephalosporin Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Cephalosporin Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Cephalosporin Sales Volume, (2020-2025) & (MT)

Table 56. Key Countries/Regions Cephalosporin Sales Volume, (2026-2031) & (MT)

Table 57. NCPC Company Information

Table 58. NCPC Introduction and Business Overview

Table 59. NCPC Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 60. NCPC Cephalosporin Product Offerings

Table 61. NCPC Recent Development

Table 62. Qilu Antibiotics Company Information

Table 63. Qilu Antibiotics Introduction and Business Overview

Table 64. Qilu Antibiotics Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 65. Qilu Antibiotics Cephalosporin Product Offerings

Table 66. Qilu Antibiotics Recent Development

Table 67. Dongying Pharmaceutical Company Information

Table 68. Dongying Pharmaceutical Introduction and Business Overview

Table 69. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 70. Dongying Pharmaceutical Cephalosporin Product Offerings

Table 71. Dongying Pharmaceutical Recent Development

Table 72. SALUBRIS Company Information

Table 73. SALUBRIS Introduction and Business Overview

Table 74. SALUBRIS Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 75. SALUBRIS Cephalosporin Product Offerings

Table 76. SALUBRIS Recent Development

Table 77. LIVZON Company Information

Table 78. LIVZON Introduction and Business Overview

Table 79. LIVZON Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 80. LIVZON Cephalosporin Product Offerings

Table 81. LIVZON Recent Development

Table 82. CSPC Company Information

Table 83. CSPC Introduction and Business Overview

Table 84. CSPC Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 85. CSPC Cephalosporin Product Offerings

Table 86. CSPC Recent Development

Table 87. United Laboratories Company Information

Table 88. United Laboratories Introduction and Business Overview

Table 89. United Laboratories Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 90. United Laboratories Cephalosporin Product Offerings

Table 91. United Laboratories Recent Development

Table 92. LKPC Company Information

Table 93. LKPC Introduction and Business Overview

Table 94. LKPC Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 95. LKPC Cephalosporin Product Offerings

Table 96. LKPC Recent Development

Table 97. HPGC Company Information

Table 98. HPGC Introduction and Business Overview

Table 99. HPGC Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 100. HPGC Cephalosporin Product Offerings

Table 101. HPGC Recent Development

Table 102. Ruiying Company Information

Table 103. Ruiying Introduction and Business Overview

Table 104. Ruiying Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 105. Ruiying Cephalosporin Product Offerings

Table 106. Ruiying Recent Development

Table 107. Meiya Company Information

Table 108. Meiya Introduction and Business Overview

Table 109. Meiya Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 110. Meiya Cephalosporin Product Offerings

Table 111. Meiya Recent Development

Table 112. Kelun Company Information

Table 113. Kelun Introduction and Business Overview

Table 114. Kelun Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 115. Kelun Cephalosporin Product Offerings

Table 116. Kelun Recent Development

Table 117. Dongrui Company Information

Table 118. Dongrui Introduction and Business Overview

Table 119. Dongrui Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 120. Dongrui Cephalosporin Product Offerings

Table 121. Dongrui Recent Development

Table 122. Liguo Pharma Company Information

Table 123. Liguo Pharma Introduction and Business Overview

Table 124. Liguo Pharma Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 125. Liguo Pharma Cephalosporin Product Offerings

Table 126. Liguo Pharma Recent Development

Table 127. Fuan Pharma Company Information

Table 128. Fuan Pharma Introduction and Business Overview

Table 129. Fuan Pharma Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 130. Fuan Pharma Cephalosporin Product Offerings

Table 131. Fuan Pharma Recent Development

Table 132. Orchid Pharma Company Information

Table 133. Orchid Pharma Introduction and Business Overview

Table 134. Orchid Pharma Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 135. Orchid Pharma Cephalosporin Product Offerings

Table 136. Orchid Pharma Recent Development

Table 137. Aurobindo Company Information

Table 138. Aurobindo Introduction and Business Overview

Table 139. Aurobindo Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 140. Aurobindo Cephalosporin Product Offerings

Table 141. Aurobindo Recent Development

Table 142. Nectar Lifesciences Company Information

Table 143. Nectar Lifesciences Introduction and Business Overview

Table 144. Nectar Lifesciences Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 145. Nectar Lifesciences Cephalosporin Product Offerings

Table 146. Nectar Lifesciences Recent Development

Table 147. ACS Dobfar Company Information

Table 148. ACS Dobfar Introduction and Business Overview

Table 149. ACS Dobfar Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 150. ACS Dobfar Cephalosporin Product Offerings

Table 151. ACS Dobfar Recent Development

Table 152. Novartis Company Information

Table 153. Novartis Introduction and Business Overview

Table 154. Novartis Cephalosporin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 155. Novartis Cephalosporin Product Offerings

Table 156. Novartis Recent Development

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Cephalosporin Downstream Customers

Table 160. Cephalosporin Distributors List

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Cephalosporin Product Picture

Figure 2. Global Cephalosporin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Cephalosporin Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Cephalosporin Sales Volume (2020-2031) & (MT)

Figure 5. Global Cephalosporin Sales Price (2020-2031) & (USD/Kg)

Figure 6. Cephalosporin Report Years Considered

Figure 7. Global Cephalosporin Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Cephalosporin Players Sales Volume Ranking (2024) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cephalosporin Revenue in 2024

Figure 10. Cephalosporin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. First Generation Cephalosporin Picture

Figure 12. Second Generation Cephalosporin Picture

Figure 13. Third Generation Cephalosporin Picture

Figure 14. Fourth Generation Cephalosporin Picture

Figure 15. Global Cephalosporin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Cephalosporin Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Cephalosporin Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)

Figure 18. Global Cephalosporin Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Cephalosporin Price by Type (2020-2031) & (USD/Kg)

Figure 20. Product Picture of Oral

Figure 21. Product Picture of Injection

Figure 22. Global Cephalosporin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Cephalosporin Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Cephalosporin Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)

Figure 25. Global Cephalosporin Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Cephalosporin Price by Application (2020-2031) & (USD/Kg)

Figure 27. North America Cephalosporin Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Cephalosporin Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Cephalosporin Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Cephalosporin Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Cephalosporin Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Cephalosporin Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Cephalosporin Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Cephalosporin Sales Volume (%), (2020-2031)

Figure 39. United States Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 45. China Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 47. China Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 57. India Cephalosporin Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Cephalosporin Sales Value by Type (%), 2024 VS 2031

Figure 59. India Cephalosporin Sales Value by Application (%), 2024 VS 2031

Figure 60. Cephalosporin Industrial Chain

Figure 61. Cephalosporin Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Beta lactam and Beta lactamase Inhibitors Market Research Report 2025

Global Cephalosporin Antibiotic Side Chain Intermediates Market Research Report 2024

Global Ceftazidime Market Insights Forecast to 2030

Global Oxycephem Antibiotics Market Research Report 2024

Cephalosporin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enzymes for β lactam Antibiotics Market Research Report 2024

Global Penem Antibiotics Market Research Report 2024

Global Cephalosporins and Intermediates Market Research Report 2024

Global Ceftaroline Fosamil Market Insights Forecast to 2030

Global Cephalosporin Antibiotics API Market Research Report 2025

Cephalosporin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cefoxitin Acid Market Research Report 2024

Global Cefepime Market Research Report 2024

Cephalexine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cefalexin API Market Insights Forecast to 2030

Global Cephalosporin Antibiotics Market Research Report 2024

Global β Lactam Antibiotics Market Research Report 2025

Cefaclor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ceftibuten Dihydrate Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions